M Bellet

939 total citations
31 papers, 574 citations indexed

About

M Bellet is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology. According to data from OpenAlex, M Bellet has authored 31 papers receiving a total of 574 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 4 papers in Surgery and 4 papers in Molecular Biology. Recurrent topics in M Bellet's work include Blood Pressure and Hypertension Studies (7 papers), Eicosanoids and Hypertension Pharmacology (3 papers) and Receptor Mechanisms and Signaling (3 papers). M Bellet is often cited by papers focused on Blood Pressure and Hypertension Studies (7 papers), Eicosanoids and Hypertension Pharmacology (3 papers) and Receptor Mechanisms and Signaling (3 papers). M Bellet collaborates with scholars based in France, Switzerland and United States. M Bellet's co-authors include Joël Ménard, Pierre Corvol, P Sassano, Christèle Kandalaft, Philippe Léger, Paul E. Verweij, Parisa Danaietash, Joël Ménard, Bruno Flamion and P Meyer and has published in prestigious journals such as Hypertension, European Heart Journal and The American Journal of Cardiology.

In The Last Decade

M Bellet

29 papers receiving 531 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Bellet France 13 321 148 112 94 92 31 574
Bühler Fr Switzerland 14 320 1.0× 199 1.3× 132 1.2× 155 1.6× 95 1.0× 75 707
Kathleen McLean United Kingdom 13 307 1.0× 228 1.5× 97 0.9× 98 1.0× 72 0.8× 22 692
Gen Yasuda Japan 15 317 1.0× 168 1.1× 172 1.5× 74 0.8× 123 1.3× 73 790
Lata Kler United Kingdom 11 206 0.6× 186 1.3× 207 1.8× 54 0.6× 95 1.0× 15 571
J. C. Pelayo United States 14 178 0.6× 241 1.6× 128 1.1× 179 1.9× 155 1.7× 19 788
M. A. Boim Brazil 9 354 1.1× 151 1.0× 170 1.5× 127 1.4× 94 1.0× 15 755
Louis Wj Australia 14 150 0.5× 133 0.9× 74 0.7× 76 0.8× 103 1.1× 29 547
F LEENEN Canada 14 437 1.4× 101 0.7× 185 1.7× 84 0.9× 71 0.8× 21 682
J. Rosenthal Germany 13 226 0.7× 166 1.1× 168 1.5× 65 0.7× 76 0.8× 38 539
Toshikazu Goto Japan 14 692 2.2× 142 1.0× 109 1.0× 91 1.0× 228 2.5× 54 1.1k

Countries citing papers authored by M Bellet

Since Specialization
Citations

This map shows the geographic impact of M Bellet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Bellet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Bellet more than expected).

Fields of papers citing papers by M Bellet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Bellet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Bellet. The network helps show where M Bellet may publish in the future.

Co-authorship network of co-authors of M Bellet

This figure shows the co-authorship network connecting the top 25 collaborators of M Bellet. A scholar is included among the top collaborators of M Bellet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Bellet. M Bellet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Verweij, Paul E., Parisa Danaietash, Bruno Flamion, Joël Ménard, & M Bellet. (2020). Randomized Dose-Response Study of the New Dual Endothelin Receptor Antagonist Aprocitentan in Hypertension. Hypertension. 75(4). 956–965. 59 indexed citations
2.
Danaietash, Parisa, Paul E. Verweij, Bruno Flamion, Joël Ménard, & M Bellet. (2019). 34Efficacy and safety of various doses of the new dual endothelin receptor antagonist aprocitentan in the treatment of hypertension. European Heart Journal. 40(Supplement_1). 2 indexed citations
3.
Jones-Burton, Charlotte, Joseph Rubino, Sophie Roy, et al.. (2010). Effects of the renin inhibitor MK-8141 (ACT-077825) in patients with hypertension. Journal of the American Society of Hypertension. 4(5). 219–226. 6 indexed citations
4.
Gräf, Peter, et al.. (1992). Unmasking of the hypotensive effect of nifedipine in normotensives by addition of the angiotensin converting enzyme inhibitor benazepril. Journal of Hypertension. 10(9). 1045???1052–1045???1052. 9 indexed citations
5.
Bellet, M, et al.. (1990). Use of crossover trials to obtain antihypertensive dose-response curves and to study combination therapy during the development of benazepril.. PubMed. 36(2). 107–113. 5 indexed citations
6.
Ménard, Joël, et al.. (1990). From the Parallel Group Design to the Crossover Design, and From the Group Approach to the Individual Approach. American Journal of Hypertension. 3(10_Pt_1). 815–819. 7 indexed citations
7.
Bellet, M, et al.. (1989). Crossover design for the dose determination of an angiotensin converting enzyme inhibitor in hypertension. Journal of Hypertension. 7(12). 1005–1012. 14 indexed citations
8.
Nussberger, J., Lucienne Juillerat, Florent Perret, et al.. (1989). Need for plasma angiotensin measurements to investigate converting-enzyme inhibition in humans. American Heart Journal. 117(3). 717–721. 37 indexed citations
9.
Bellet, M, Jean-Yves Pagny, Gilles Châtellier, Pierre Corvol, & Joël Ménard. (1987). Evaluation of Slow Release Nicardipine in Essential Hypertension by Casual and Ambulatory Blood Pressure Measurements. Effects of Acute Versus Chronic Administration. Journal of Hypertension. 5(5). 599–604. 18 indexed citations
10.
Bellet, M, P Sassano, T T Guyenne, Pierre Corvol, & Joël Ménard. (1987). Converting‐enzyme inhibition buffers the counter‐regulatory response to acute administration of nicardipine.. British Journal of Clinical Pharmacology. 24(4). 465–472. 41 indexed citations
11.
Forette, F, et al.. (1985). Effect of nicardipine in elderly hypertensive patients.. British Journal of Clinical Pharmacology. 20(S1). 125S–129S. 46 indexed citations
12.
Bellet, M, Y Loria, & A Lallemand. (1985). First-Step Treatment of Mild to Moderate Uncomplicated Essential Hypertension by a New Calcium Antagonist: Nicardipine. Journal of Cardiovascular Pharmacology. 7(6). 1149–1153. 26 indexed citations
13.
Bellet, M, Christèle Kandalaft, P Sassano, et al.. (1985). Systemic hypertension after cardiac transplantation: Effect of cyclosporine on the renin-angiotensin-aldosterone system. The American Journal of Cardiology. 56(15). 927–931. 112 indexed citations
14.
Battaglia, Cristina, et al.. (1985). The Antlhypertensive Effect of Nicardipine (Long-Acting Form), Renin Activity and Divalent Cations. Journal of Hypertension. 3(5). 553–553. 1 indexed citations
15.
Sébert, P., et al.. (1984). Ventilatory and Occlusion Pressure Responses to Hypercapnia in Patients with Chronic Renal Failure. Respiration. 45(3). 191–196. 7 indexed citations
16.
Grünfeld, J P & M Bellet. (1982). [Arterial hypertension induced by drugs].. PubMed. 3(4). 167–70. 1 indexed citations
17.
Meyer, Philippe, Ricardo P. Garay, Corinne Nazaret, et al.. (1981). Inheritance of abnormal erythrocyte cation transport in essential hypertension.. BMJ. 282(6270). 1114–1117. 48 indexed citations
18.
Bellet, M, et al.. (1981). Central hypotensive effect of diprenorphine in normotensive rat and SHR.. PubMed. 252(1). 147–51. 4 indexed citations
19.
Bellet, M, J. L. Elghozi, P Meyer, Marie-Gabrielle Pernollet, & H. Schmitt. (1980). CENTRAL CARDIOVASCULAR EFFECTS OF NARCOTIC ANALGESICS AND ENKEPHALINS IN RATS. British Journal of Pharmacology. 71(2). 365–369. 55 indexed citations
20.
Bellet, M, et al.. (1979). [Cholangio-carcinoma arising in Caroli's disease (author's transl)].. PubMed. 27(2). 121–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bühler Fr Breakdown of academic impact, for papers by Kathleen McLean Breakdown of academic impact, for papers by Gen Yasuda Breakdown of academic impact, for papers by Lata Kler Breakdown of academic impact, for papers by J. C. Pelayo Breakdown of academic impact, for papers by M. A. Boim Breakdown of academic impact, for papers by Louis Wj Breakdown of academic impact, for papers by F LEENEN Breakdown of academic impact, for papers by J. Rosenthal Breakdown of academic impact, for papers by Toshikazu Goto
Rankless by CCL
2026